SCYNEXIS Inc (SCYX) stock
SCYXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3072% below fair value
$2.82−0.03 (-1.05%)
Close on Nov 18, 2026Market cap $28.06MP/E –Yield –
Scynexis net income
Net income is the profit left for shareholders after every expense, interest and tax.
Scynexis's net income for the twelve months ending Jun 30, 2026 was -$10.24M. For fiscal 2025 it was -$8.61M. The highest annual figure on record is $67.04M in fiscal 2023.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$8.61M | – |
| FY2024 | Dec 31, 2024 | -$21.29M | -131.8% |
| FY2023 | Dec 31, 2023 | $67.04M | – |
| FY2022 | Dec 31, 2022 | -$62.81M | – |
| FY2021 | Dec 31, 2021 | -$32.87M | – |
| FY2020 | Dec 31, 2020 | -$55.19M | – |
| FY2019 | Dec 31, 2019 | -$53.71M | – |
| FY2018 | Dec 31, 2018 | -$12.47M | – |
| FY2017 | Dec 31, 2017 | -$25.06M | – |
| FY2016 | Dec 31, 2016 | -$29.99M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $7.40M | – |
| Q1 FY2026 | Mar 31, 2026 | -$21.30M | – |
| Q4 FY2025 | Dec 31, 2025 | $12.26M | – |
| Q3 FY2025 | Sep 30, 2025 | -$8.59M | – |
| Q2 FY2025 | Jun 30, 2025 | -$6.89M | – |
| Q1 FY2025 | Mar 31, 2025 | -$5.39M | -1411.7% |
| Q4 FY2024 | Dec 31, 2024 | -$4.43M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.81M | – |
| Q2 FY2024 | Jun 30, 2024 | -$14.46M | -111.8% |
| Q1 FY2024 | Mar 31, 2024 | $411.00K | – |
| Q4 FY2023 | Dec 31, 2023 | -$19.59M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.76M | – |
| Q2 FY2023 | Jun 30, 2023 | $122.26M | – |
| Q1 FY2023 | Mar 31, 2023 | -$33.88M | – |
| Q4 FY2022 | Dec 31, 2022 | -$14.43M | – |
| Q3 FY2022 | Sep 30, 2022 | -$29.58M | – |
| Q2 FY2022 | Jun 30, 2022 | -$13.35M | -904.9% |
| Q1 FY2022 | Mar 31, 2022 | -$5.45M | – |
| Q4 FY2021 | Dec 31, 2021 | -$29.24M | – |
| Q3 FY2021 | Sep 30, 2021 | -$605.00K | -166.6% |
| Q2 FY2021 | Jun 30, 2021 | $1.66M | – |
| Q1 FY2021 | Mar 31, 2021 | -$4.68M | – |
| Q4 FY2020 | Dec 31, 2020 | -$42.71M | – |
| Q3 FY2020 | Sep 30, 2020 | $909.00K | – |
| Q2 FY2020 | Jun 30, 2020 | -$6.38M | – |
| Q1 FY2020 | Mar 31, 2020 | -$7.00M | – |
| Q4 FY2019 | Dec 31, 2019 | -$14.46M | -844.5% |
| Q3 FY2019 | Sep 30, 2019 | -$7.94M | -2362.4% |
| Q2 FY2019 | Jun 30, 2019 | -$8.40M | – |
| Q1 FY2019 | Mar 31, 2019 | -$22.91M | – |
| Q4 FY2018 | Dec 31, 2018 | $1.94M | – |
| Q3 FY2018 | Sep 30, 2018 | $351.00K | – |
| Q2 FY2018 | Jun 30, 2018 | -$10.76M | – |
| Q1 FY2018 | Mar 31, 2018 | -$4.00M | – |
| Q4 FY2017 | Dec 31, 2017 | -$7.59M | – |
| Q3 FY2017 | Sep 30, 2017 | -$8.40M | – |
| Q2 FY2017 | Jun 30, 2017 | -$4.20M | – |
| Q1 FY2017 | Mar 31, 2017 | -$4.87M | – |
| Q4 FY2016 | Dec 31, 2016 | -$3.45M | – |
| Q3 FY2016 | Sep 30, 2016 | -$11.23M | – |
See a number that looks wrong?